Verano Holdings Corp. (VRNOF)
(Delayed Data from OTC)
$3.62 USD
-0.28 (-7.18%)
Updated Aug 2, 2024 03:59 PM ET
4-Sell of 5 4
B Value B Growth B Momentum A VGM
Brokerage Reports
0 items in cart
Verano Holdings Corp. [VRNOF]
Reports for Purchase
Showing records 61 - 80 ( 145 total )
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: States Taking Initiative on 280E Tax Relief Front
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: Comparing U.S. Cannabis Cash Flows Tax Adjustments
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: New York''s Revised Regulations the First Step
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: Midwestern States Represent The Next Legalization Wave
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
1Q23 Solid, Profits and FCF Remain Strong in Challenging Market
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: 1Q23 Reports on Deck, Cash Flow Generation Focus in Tough Market
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: U.S. State Legalization Progressing
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: Consumer & Generation Preferences - 4/20 Special
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: MSO Benchmarking Scorecard Update - Prioritizing Cash Flows
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: Germany''s Adult-Use Legalization Pivoting
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
Quality at a Discount: FCF Yield of 15% in H223 Provides Optionality to Accelerate Organic or Inorganic Growth
Provider: Echelon Welath Partners
Analyst: SEMPLE A
Company: Verano Holdings Corp.
Industry: Medical - Products
Consumer- Weekly ReHash: Another Rough Quarter for Cannabis
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Results Remain Solid Despite Market Conditions, Positive FCF Provides Verano Optionality on Pace of Growth or Paying Down Debt
Provider: Echelon Welath Partners
Analyst: SEMPLE A
Company: Verano Holdings Corp.
Industry: Medical - Products
4Q22 Inline, Efficient Lean Ops in Place to Drive FCF in ''23, PT to $10
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
35th Annual Roth Conference Health & Wellness Takeaways
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S